|
|
DRD96417
|
Detroit R&D |
|
50 uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GST-ANTI-1
|
Detroit R&D |
|
50 uL |
|
|
|
GST-ANTI-2
|
Detroit R&D |
|
50 uL |
|
|
|
GST-ANTI-3
|
Detroit R&D |
|
50 uL |
|
|
|
GSTANTI1
|
Detroit R&D |
|
50 uL |
|
|
|
GSTANTI2
|
Detroit R&D |
|
50 uL |
|
|
|
GSTANTI3
|
Detroit R&D |
|
50 uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EB-1
|
Detroit R&D |
|
81 vials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DRD96930
|
Detroit R&D |
|
50 uL |
|
|
|
EB-2
|
Detroit R&D |
|
27 vials |
|
|
|
EB-3
|
Detroit R&D |
|
27 vials |
|
|
|
EB-4
|
Detroit R&D |
|
27 vials |
|
|
|
|
|
P2C11PT
|
Detroit R&D |
|
50 uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|